tiprankstipranks
Insperity Inc (NSP)
NYSE:NSP
Holding NSP?
Track your performance easily

Insperity (NSP) Income Statement

332 Followers

Insperity Income Statement

Last quarter (Q3 2024), Insperity's total revenue was $1.56B, an increase of 0.64% from the same quarter last year. In Q3, Insperity's net income was $3.00M. See Insperity’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 6.55B$ 6.49B$ 5.94B$ 4.97B$ 4.29B$ 4.31B
Cost of Revenue
$ 1.36B$ 5.45B$ 4.93B$ -4.15B$ -3.48B$ -3.58B
Gross Profit
$ 2.51B$ 1.04B$ 1.01B$ 820.10M$ 806.85M$ 7.90B
Operating Expense
$ 901.82M$ 818.25M$ 760.99M$ 646.77M$ 612.16M$ 546.30M
Operating Income
$ 154.27M$ 218.55M$ 250.24M$ 173.33M$ 194.69M$ 186.63M
Net Non Operating Interest Income Expense
$ -1.23M$ 6.53M$ -4.81M$ -5.01M$ -5.42M$ 3.01M
Other Income Expense
------
Pretax Income
$ 163.05M$ 225.08M$ 245.43M$ 168.32M$ 189.27M$ 189.64M
Tax Provision
$ 43.48M$ 53.70M$ 66.08M$ 44.24M$ 51.03M$ 38.54M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 119.56M$ 171.38M$ 179.35M$ 124.08M$ 137.46M$ 149.34M
Basic EPS
$ 3.19$ 4.53$ 4.70$ 3.22$ 3.57$ 3.72
Diluted EPS
$ 3.16$ 4.47$ 4.64$ 3.18$ 3.54$ 3.70
Basic Average Shares
$ 150.28M$ 37.81M$ 38.12M$ 38.43M$ 38.50M$ 40.19M
Diluted Average Shares
$ 151.92M$ 38.34M-$ 38.43M$ 38.50M$ 40.19M
Dividend Per Share
$ 2.34-----
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -456.30M$ 6.27B$ 5.69B$ -3.51B$ -2.87B$ -3.04B
Net Income From Continuing And Discontinued Operation
$ 119.56M$ 171.38M$ 179.35M$ 124.08M$ 138.24M$ 151.10M
Normalized Income
$ 20.25M$ 177.81M$ 243.97M$ 132.97M--
Interest Expense
------
EBIT
$ 1.80B$ 252.22M$ 259.63M$ 175.78M$ 197.29M$ 197.29M
EBITDA
$ 1.84B$ 294.92M$ 300.29M$ 214.32M$ 228.47M$ 226.01M
Currency in USD

Insperity Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis